ID #54 'How to' Session
Tracks
Shiraz Room A
| Friday, November 8, 2019 |
| 9:00 AM - 11:00 AM |
| Shiraz Room A |
Presentation
Keynote Speaker: A/Professor Benjamin Hampstead
Presenter(s)
Associate Professor Benjamin Hampstead
University of Michigan
Non-invasive brain stimulation as a cognitive enhancement tool
9:00 AM - 11:00 AMSummary
Non-invasive brain stimulation comprises a range of methods that introduce energy (e.g., via electricity, magnets, sound/light waves) into the brain with the goal of modulating activity in key brain regions and networks. Although common in the cognitive neurosciences, these tools are becoming increasingly popular in patient populations given this direct neuromodulatory potential. Thus, clinical providers are likely to encounter and, perhaps, even provide such approaches in their everyday practice. Therefore, this workshop will provide an overview of commonly used brain stimulation techniques including transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), and transcranial magnetic stimulation (TMS). Examples of equipment, set up, administration, and use/efficacy will be provided. Known dosing parameters (or the lack thereof) will be provided when available. By the end of the session, participants will be able to identify and describe three commonly used forms of neuromodulation as well as strengths and weaknesses of each approach.
.....
Dr. Hampstead is a board-certified Clinical Neuropsychologist who earned his PhD in Clinical Psychology (Neuropsychology emphasis) from Drexel University. He is an Associate Professor of Psychiatry at the University of Michigan, Staff Neuropsychologist in the VA Ann Arbor Healthcare System, and Clinical Core Leader of the NIA funded Michigan Alzheimer’s Disease Research Center. Dr. Hampstead’s research focuses on non-pharmacologic approaches to maximize cognitive functioning in older adults across the dementia spectrum. Specifically, he uses cognitively oriented treatments and non-invasive brain stimulation to enhance cognition, typically within the context of a randomized controlled trial format. Dr. Hampstead integrates these techniques with functional and structural neuroimaging in order to predict treatment response, identify the neuroplastic changes following treatment, and plan/develop new interventions. Ongoing work integrates amyloid and tau positron emission tomography (PET) in order to better characterize participant characteristics associated with treatment response. He has maintained continuous federal funding for his work since earning his doctorate (13+ years), with most support from the Department of Veterans Affairs and National Institute on Aging.
